Quantitative Magnetoencephalography of Spontaneous Brain Activity in Alzheimer Disease: An Exhaustive Frequency Analysis

Quantitative magnetoencephalography (qMEG) was used to investigate differences in the 2 to 60 Hz spectral power, between Alzheimer disease (AD) patients and control subjects. Twenty-two AD patients and 21 age-matched control subjects participated in this study. MEG signal analysis comprised the division of the entire 2 to 60 Hz spectrum in 2 Hz-width subbands. Both the relative power and the contribution of each subband to the correct classification of AD patients and controls were calculated. The relative power in 2 bands comprised between 2 to 4 Hz and 16 to 28 Hz was selected by a restrictive multiple-comparison test, among the entire 2 to 60 Hz spectrum. Using 2 to 4 Hz values it is possible to choose a classification rule with an estimate sensitivity and specificity given by 68% and 76% respectively. Alternatively, when 16 to 28 Hz values are used, it is possible to obtain a better classification rule with an estimate sensitivity and specificity given by 81% and 80%, respectively. To the best of our knowledge, this is the first electroencephalography or MEG study where a so exhaustive analysis of the magneto-electric spectrum has been performed. This study supports the notion that more attention should be devoted to the study of β band in AD.

[1]  Luisa Minghetti,et al.  Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats , 2004, Experimental Neurology.

[2]  A. Nordberg,et al.  Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease , 2000, Neurobiology of Aging.

[3]  Stephen A. Dyer,et al.  Digital signal processing , 2018, 8th International Multitopic Conference, 2004. Proceedings of INMIC 2004..

[4]  M. Siepmann,et al.  Pharmacokinetics and Pharmacodynamics of Scopolamine after Subcutaneous Administration , 1998, Journal of clinical pharmacology.

[5]  B. Gueguen,et al.  Apport de l'EEG quantifié au diagnostic de démence de type Alzheimer , 1991, Neurophysiologie Clinique/Clinical Neurophysiology.

[6]  Nariyoshi Yamaguchi,et al.  Electroencephalographic abnormalities in patients with presenile dementia of the Alzheimer type: Quantitative analysis at rest and during photic stimulation , 1997, Biological Psychiatry.

[7]  Oscar U. Scremin,et al.  Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgG-saporin , 1999, Experimental Brain Research.

[8]  G. Buzsáki,et al.  Electric activity in the neocortex of freely moving young and aged rats , 1988, Neuroscience.

[9]  T Dierks,et al.  Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study , 2000, Clinical Neurophysiology.

[10]  Thomas Dierks,et al.  Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease , 2000, Clinical Neurophysiology.

[11]  Thomas Dierks,et al.  Dementia of the alzheimer type: Effects on the spontaneous EEG described by dipole sources , 1993, Psychiatry Research: Neuroimaging.

[12]  V. Knott,et al.  Quantitative electroencephalography in Alzheimer's disease: comparison with a control group, population norms and mental status. , 2001, Journal of psychiatry & neuroscience : JPN.

[13]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[14]  Alberto Fernández,et al.  Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: volumetric MR imaging-magnetoencephalographic study. , 2003, AJNR. American journal of neuroradiology.

[15]  G. Buzsáki,et al.  The cholinergic system and EEG slow waves. , 1991, Electroencephalography and clinical neurophysiology.

[16]  M C Bourdel,et al.  [Quantified EEG in the diagnosis of Alzheimer's type dementia]. , 1991, Neurophysiologie clinique = Clinical neurophysiology.

[17]  J. Ridley.  Studies of Interference in Serial Verbal Reactions , 2001 .

[18]  R. DeTeresa,et al.  Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease , 1988, Neurology.

[19]  Claudio Babiloni,et al.  Abnormal fronto‐parietal coupling of brain rhythms in mild Alzheimer's disease: a multicentric EEG study , 2004, The European journal of neuroscience.

[20]  P Gloor,et al.  Brain lesions that produce delta waves in the EEG , 1977, Neurology.

[21]  R. Ilmoniemi,et al.  Magnetoencephalography-theory, instrumentation, and applications to noninvasive studies of the working human brain , 1993 .

[22]  A. Leuchter,et al.  Beta activity in aging and dementia , 2005, Brain Topography.

[23]  K. D. Singh,et al.  Magnetic field tomography of coherent thalamocortical 40-Hz oscillations in humans. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Leuchter,et al.  Attenuation of brain high frequency electrocortical response after thiopental in early stages of Alzheimer’s dementia , 2000, Psychopharmacology.

[25]  L. Wahlund,et al.  Quantitative EEG Abnormalities and Cognitive Dysfunctions in Frontotemporal Dementia and Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[26]  R. Ilmoniemi,et al.  Alzheimer's disease affects parallel processing between the auditory cortices. , 1996, Neuroreport.

[27]  P. Eikelenboom,et al.  Complement C4 phenotypes in dementia of the Alzheimer type. , 1988, Human heredity.

[28]  O Almkvist,et al.  Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. , 1996, Dementia.

[29]  W. Sannita,et al.  Effects of scopolamine (0.25-0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers. , 1987, Neuropsychobiology.

[30]  S. Uijtdehaage,et al.  Loss of High-Frequency Brain Electrical Response to Thiopental Administration in Alzheimer's-Type Dementia , 1997, Neuropsychopharmacology.

[31]  D. Treiman,et al.  Changes in cortical EEG and cholinergic function in response to NGF in rats with nucleus basalis lesions , 1997, Brain Research.

[32]  Thomas Dierks,et al.  Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type , 1996, Biological Psychiatry.

[33]  M. Kikuchi,et al.  Effects of Scopolamine on Interhemispheric EEG Coherence in Healthy Subjects: Analysis during Rest and Photic Stimulation , 2000, Clinical EEG.

[34]  B. Rockstroh,et al.  Focal temporoparietal slow activity in Alzheimer’s disease revealed by magnetoencephalography , 2002, Biological Psychiatry.

[35]  K. Meguro,et al.  Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[36]  G. Rondouin,et al.  Diagnostic value of quantitative EEG in Alzheimer’s disease , 2001, Neurophysiologie Clinique/Clinical Neurophysiology.

[37]  M. Filippi,et al.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[38]  H. Dringenberg,et al.  Alzheimer's disease: more than a ‘cholinergic disorder' — evidence that cholinergic–monoaminergic interactions contribute to EEG slowing and dementia , 2000, Behavioural Brain Research.

[39]  Y. Parmet,et al.  Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls. , 1994, Electroencephalography and clinical neurophysiology.

[40]  L. Bour,et al.  Determinants of Quantitative Spectral Electroencephalography in Early Alzheimer’s Disease: Cognitive Function, Regional Cerebral Blood Flow, and Computed Tomography , 2000, Dementia and Geriatric Cognitive Disorders.

[41]  E. Mori,et al.  Impact of White Matter Changes on Clinical Manifestation of Alzheimer’s Disease: A Quantitative Study , 2000, Stroke.

[42]  B. Saletu.  EEG Brain Mapping in Diagnostic and Therapeutic Assessment of Dementia , 1991, Alzheimer disease and associated disorders.

[43]  T Gasser,et al.  Quantitative EEG analysis in early onset Alzheimer's disease: a controlled study. , 1993, Electroencephalography and clinical neurophysiology.

[44]  Claudio Del Percio,et al.  Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multicentric EEG study , 2004, NeuroImage.

[45]  Jyrki Ahveninen,et al.  Effects of scopolamine on MEG spectral power and coherence in elderly subjects , 2003, Clinical Neurophysiology.

[46]  Risto Näätänen,et al.  Impaired preconscious auditory processing and cognitive functions in Alzheimer's disease , 1999, Clinical Neurophysiology.

[47]  E. Jonkman,et al.  The role of the electroencephalogram in the diagnosis of dementia of the Alzheimer type: an attempt at technology assessment , 1997, Neurophysiologie Clinique/Clinical Neurophysiology.

[48]  B. W van Dijk,et al.  Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study , 2000, Clinical Neurophysiology.